Calcium channel blockers: more than 50 years on guard of health

• Main Authors: I E Chazova, Yu V Zhernakova
• Format: Article
• Language: Russian
• Published: IP Morozov P.V. 2015-06-01
• Series: Системные гипертензии
• Subjects: arterial hypertension; antihypertensive therapy; calcium channel blockers
• Online Access: https://syst-hypertension.ru/2075-082X/article/viewFile/29074/pdf

The class of drugs - calcium antagonists (CA), or calcium channel blockers (CCBs) is combined a quite heterogeneous drugs group possessing common vasodilatatory characteristics by disruption of the movement of calcium through the vascular smooth muscle cells and with different degree of impact on myocardium, the sinus node function, atrioventricular conduction, tonus of peripheral vessels and coronary blood flow. The existence of this class of drugs has become one of the great achievements in the field of pharmacology, at the end of the 20th century. Third Generation CCBs takes the special place in hypertensiology because of high bioavailability and tissue selectivity. Modern long-acting CA are widely used in case of arterial hypertension (AH), they can be used especially in patients with diabetes mellitus, peripheral artery disease, chronic obstructive pulmonary disease and bronchial asthma, ischemic heart disease and in elderly patients with systolic AH. These drugs show not only antihypertensive effect and organoprotective characteristics, but also can improve the prognosis in patients with high and very high cardiovascular risk.